Stockreport

Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported Pain

Aptinyx Inc.  (APTX) 
Last aptinyx inc. earnings: 3/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aptinyx.com/investors-media
PDF NYX-2925 demonstrated statistically significant effects on a range of neuroimaging biomarkers and patient-reported outcomes, including pain scores Neuroimaging biomarke [Read more]